News | February 23, 2024
Moderna posts Q4 2023 revenue at US$ 2.8 billion
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
These digital avenues have not only revolutionized patient care but also opened up new opportunities for HCPs to build thought leadership in their respective fields
The agreement sets terms under which POC will manufacture the product or receive royalties
The company's SaaS solutions are tailored to enhance accessibility, efficiency, and patient-centricity in healthcare operations
Pelabresib recently met its primary endpoint of spleen volume reduction and demonstrated favorable trends in symptom improvement
Collaboration streamlines patient access to oncology clinical trials
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Subscribe To Our Newsletter & Stay Updated
